Safety, Tolerability and Pharmacokinetic Profile of BPI-15086 in EGFR T790M Mutation-positive NSCLC Patients
Clinical trial NCT02914990 · COMPLETED
Trial details
- NCT number
- NCT02914990
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-29
- Primary completion
- 2019-03-07
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.